These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20031839)

  • 21. Gauging the treatment gap in dyslipidemia: findings from the 1999-2000 National Health and Nutrition Examination Survey.
    Klingman D; Williams SA; Benner JS; Smith TW; Ahn J; O'Donnell JC
    Am Heart J; 2005 Sep; 150(3):595-601. PubMed ID: 16169347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of dyslipidemia in rural Thai adults: an epidemiologic study in Khon Kaen province.
    Pongchaiyakul C; Pongchaiyakul C; Pratipanawatr T
    J Med Assoc Thai; 2005 Aug; 88(8):1092-7. PubMed ID: 16404837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contemporary management of dyslipidemia in high-risk patients: targets still not met.
    Yan AT; Yan RT; Tan M; Hackam DG; Leblanc KL; Kertland H; Tsang JL; Jaffer S; Kates ML; Leiter LA; Fitchett DH; Langer A; Goodman SG;
    Am J Med; 2006 Aug; 119(8):676-83. PubMed ID: 16887414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Middle-aged women's awareness of cholesterol as a risk factor: results from a national survey of Korean Middle-aged Women's Health Awareness (KomWHA) study.
    Choi EJ; Jekal Y; Kim S; Yoo JS; Kim HS; Oh EG; Jeon JY; Jang Y; Chu SH; Kim MJ
    Int J Nurs Stud; 2010 Apr; 47(4):452-60. PubMed ID: 19819450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men--the Tanno and Sobetsu Study.
    Takeuchi H; Saitoh S; Takagi S; Ohnishi H; Ohhata J; Isobe T; Shimamoto K
    Hypertens Res; 2005 Mar; 28(3):203-8. PubMed ID: 16097362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
    Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of health promotion behavior in women without prior history of coronary heart disease.
    Thanavaro JL; Moore SM; Anthony M; Narsavage G; Delicath T
    Appl Nurs Res; 2006 Aug; 19(3):149-55. PubMed ID: 16877194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: the Bogalusa Heart Study.
    Srinivasan SR; Frontini MG; Xu J; Berenson GS
    Pediatrics; 2006 Jul; 118(1):201-6. PubMed ID: 16818566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment.
    Hyre AD; Fox CS; Astor BC; Cohen AJ; Muntner P
    Am J Kidney Dis; 2007 Jan; 49(1):37-45. PubMed ID: 17185144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors of Hong Kong Chinese patients with coronary heart disease.
    Chair SY; Lee SF; Lopez V; Ling EM
    J Clin Nurs; 2007 Jul; 16(7):1278-84. PubMed ID: 17584346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
    McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
    Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Awareness and misconception of hypertension in Canada: results of a national survey.
    Petrella RJ; Campbell NR
    Can J Cardiol; 2005 May; 21(7):589-93. PubMed ID: 15940357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome in dyslipidemia consultations.
    Monteiro S; Dias P; Madeira S; de Moura P; Silva JM; Providência LA; Alves de Moura JJ
    Rev Port Cardiol; 2006 Sep; 25(9):821-31. PubMed ID: 17100172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey.
    Hirsch AT; Murphy TP; Lovell MB; Twillman G; Treat-Jacobson D; Harwood EM; Mohler ER; Creager MA; Hobson RW; Robertson RM; Howard WJ; Schroeder P; Criqui MH;
    Circulation; 2007 Oct; 116(18):2086-94. PubMed ID: 17875966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
    Ko M; Kim MT; Nam JJ
    Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of dyslipidemia and general ineffectiveness of its treatment in both primary and secondary prevention of coronary heart disease within family medicine framework--results of LIPIDOGRAM 2005--a nationwide epidemiological study. Dyslipidemia in Poland--ineffective treatment.
    Konduracka E; Jóźwiak J; Mastej M; Lukas W; Tykarski A; Szczepaniak-Chicheł L; Piwowarska W
    Przegl Lek; 2008; 65(12):834-7. PubMed ID: 19441674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Condom awareness and use in the Arusha and Kilimanjaro regions, Tanzania: a population-based study.
    Mnyika KS; Klepp KI; Kvåle G; Schreiner A; Seha AM
    AIDS Educ Prev; 1995 Oct; 7(5):403-14. PubMed ID: 8672393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.